The Crucial Significance of Lifestyle Changes

Any change towards a healthier lifestyle, even if it seems small, can have a great impact, particularly in patients with diabetes. These changes are never too late. In consequence, as physicians, we should always be attentive and never stop encouraging patients to adopt them.

La trascendental importancia de los cambios en el estilo de vidaPatients with diabetes who make changes to their lifestyle, such as eating healthy or becoming physically active, are at a lower risk of developing cardiovascular disease or even dying from cardiovascular causes than diabetic patients who fail to incorporate these healthy habits. The other piece of good news in this article that was recently published in J Am Coll Cardiol is that it is never too late to change.

 

Lifestyle modification is one of the fundamental aspects of diabetes management and adopting healthy behaviors is associated with a reduction in the risk of cardiometabolic diseases and mortality in the general population.


Read also: Are Abdominal Aortic Aneurysm Screening Programs Overstated?


This analysis included 11,527 patients diagnosed with type 2 diabetes who were followed up for 13.3 years. During that period, there were 2311 cardiovascular events.

 

The modifiable lifestyle factors registered included a healthy eating index score, smoking status (never, past, current), physical activity (≥150 minutes/week of moderate activity), and low-risk alcohol consumption (5-15 g/day for women and 5-30 g/day for men).


Read also: Urgent/Emergent TAVR: A Valid Option.


For those who adopted at least one of these low-risk lifestyle behaviors, there was a 38% reduction in the risk of cardiovascular disease compared with individuals who made no lifestyle changes. Of course, there was a gradient; the greater the change, the lower the risk. For those who adopted 3 or more lifestyle behaviors, the reduction in risk was even greater (hazard ratio [HR]: 0.48; 95% confidence interval [CI]: 0.40 to 0.59). Among individuals who changed the most, the reduction in risk entailed a reduction in mortality (HR: 0.32; 95% CI: 0.22-0.47) compared to those who made no change at all.

 

Conclusion

In patients with type 2 diabetes, the greater the adherence to a healthy lifestyle, the lower the incidence of cardiovascular disease and cardiovascular death. These findings support the enormous benefits of making lifestyle changes and the importance of medical advice for all of our patients.

 

Original title: Influence of Lifestyle on Incident Cardiovascular Disease and Mortality in Patients with Diabetes Mellitus.

Reference: Liu G et al. J Am Coll Cardiol. 2018;71:2867-2876.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...